Prevalence of dyslipidaemia and factors associated with dyslipidaemia among South Asian adults: The Center for Cardiometabolic Risk Reduction in South Asia Cohort Study.


Journal

The National medical journal of India
ISSN: 0970-258X
Titre abrégé: Natl Med J India
Pays: India
ID NLM: 8809315

Informations de publication

Date de publication:
Historique:
entrez: 27 4 2021
pubmed: 28 4 2021
medline: 29 10 2021
Statut: ppublish

Résumé

. The pattern of dyslipidaemia in South Asia is believed to be different from that in other parts of the world. Nonetheless, limited population-based data are available from the region. We assessed the prevalence, types of, and factors associated with dyslipidaemia among South Asians. . We used baseline data (2010-11) of the Center for Cardiometabolic Risk Reduction in South Asia (CARRS) cohort of 16 287 representative urban adults aged ≥20 years from Chennai and Delhi in India and Karachi in Pakistan. Total cholesterol (TC) was measured by the enzymatic-cholesterol oxidase peroxidase method, high-density lipoprotein-cholesterol (HDL-C) by the direct homogeneous method and triglycerides (TG) by enzymatic methods. Low-density lipoprotein-cholesterol (LDL-C) was calculated using Friedewald's formula. We defined high TC ≥200 mg/dl or on medication; hypertriglyceridaemia ≥150 mg/dl, high LDL-C ≥130 mg/dl or on medication and low HDL-C <40 mg/dl for males, <50 mg/dl for females. Multivariate logistic regression was carried out to assess the factors associated with dyslipidaemia. . The prevalence of any dyslipidaemia was 76.4%, 64.3% and 68.5% among males and 89.3%, 74.4% and 79.4% among females in Chennai, Delhi and Karachi, respectively. The prevalence of elevated TC was higher in Chennai compared to Delhi and Karachi (31.3%, 28.8% and 22.9%, respectively); males had a significantly greater prevalence of high TG, whereas females had a greater prevalence of low HDL-C in all the three cities. The most common lipid abnormality in all three cities was low HDL-C, which was seen in 67.1%, 49.7% and 61.3% in Chennai, Delhi and Karachi, respectively. Only 2% of the participants were on lipid-lowering drugs. Adjusted for other factors, dyslipidaemia was positively associated with age, female sex, obesity, hypertension, diabetes and tobacco use. . Overall, almost seven in ten adults in urban South Asia have some form of dyslipidaemia, and the predominant subtypes were low HDL-C and high TG.

Sections du résumé

Background
. The pattern of dyslipidaemia in South Asia is believed to be different from that in other parts of the world. Nonetheless, limited population-based data are available from the region. We assessed the prevalence, types of, and factors associated with dyslipidaemia among South Asians.
Methods
. We used baseline data (2010-11) of the Center for Cardiometabolic Risk Reduction in South Asia (CARRS) cohort of 16 287 representative urban adults aged ≥20 years from Chennai and Delhi in India and Karachi in Pakistan. Total cholesterol (TC) was measured by the enzymatic-cholesterol oxidase peroxidase method, high-density lipoprotein-cholesterol (HDL-C) by the direct homogeneous method and triglycerides (TG) by enzymatic methods. Low-density lipoprotein-cholesterol (LDL-C) was calculated using Friedewald's formula. We defined high TC ≥200 mg/dl or on medication; hypertriglyceridaemia ≥150 mg/dl, high LDL-C ≥130 mg/dl or on medication and low HDL-C <40 mg/dl for males, <50 mg/dl for females. Multivariate logistic regression was carried out to assess the factors associated with dyslipidaemia.
Results
. The prevalence of any dyslipidaemia was 76.4%, 64.3% and 68.5% among males and 89.3%, 74.4% and 79.4% among females in Chennai, Delhi and Karachi, respectively. The prevalence of elevated TC was higher in Chennai compared to Delhi and Karachi (31.3%, 28.8% and 22.9%, respectively); males had a significantly greater prevalence of high TG, whereas females had a greater prevalence of low HDL-C in all the three cities. The most common lipid abnormality in all three cities was low HDL-C, which was seen in 67.1%, 49.7% and 61.3% in Chennai, Delhi and Karachi, respectively. Only 2% of the participants were on lipid-lowering drugs. Adjusted for other factors, dyslipidaemia was positively associated with age, female sex, obesity, hypertension, diabetes and tobacco use.
Discussion
. Overall, almost seven in ten adults in urban South Asia have some form of dyslipidaemia, and the predominant subtypes were low HDL-C and high TG.

Identifiants

pubmed: 33904416
pii: NatlMedJIndia_2020_33_3_137_314005
doi: 10.4103/0970-258X.314005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

137-145

Commentaires et corrections

Type : CommentIn

Déclaration de conflit d'intérêts

None

Auteurs

Zafar Fatmi (Z)

Aga Khan University (AKU), Karachi, Pakistan.

Dimple Kondal (D)

Public Health Foundation of India (PHFI), Gurugram, Haryana, India and Centre for Chronic Disease Control, New Delhi, India.

Roopa Shivashankar (R)

Centre for Chronic Disease Control, New Delhi, India.

Romaina Iqbal (R)

Aga Khan University (AKU), Karachi, Pakistan.

Adeel Ahmed Khan (AA)

Aga Khan University (AKU), Karachi, Pakistan.

Deepa Mohan (D)

Madras Diabetes Research Foundation (MDRF) and Dr Mohan's Diabetes Specialities Centre, Chennai, India.

Rajendra Pradeepa (R)

Madras Diabetes Research Foundation (MDRF) and Dr Mohan's Diabetes Specialities Centre, Chennai, India.

Ruby Gupta (R)

Public Health Foundation of India (PHFI), Gurugram, Haryana, India.

Mohammed K Ali (MK)

Hubert, Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.

Vamadevan S Ajay (VS)

Centre for Chronic Disease Control, New Delhi, India.

Viswanathan Mohan (V)

Madras Diabetes Research Foundation (MDRF) and Dr Mohan's Diabetes Specialities Centre, Chennai, India.

Muhammad Masood Kadir (MM)

Aga Khan University (AKU), Karachi, Pakistan.

K M Venkat Narayan (KMV)

Hubert, Department of Global Health, Emory University Rollins School of Public Health, Atlanta, Georgia, USA.

Dorairaj Prabhakaran (D)

Public Health Foundation of India (PHFI), Gurugram, Haryana, India and Centre for Chronic Disease Control, New Delhi, India.

Nikhil Tandon (N)

Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH